BioSpace News Archive

Drug Development

Alios BioPharma Presented Positive Results Of Its Anti-RSV Nucleoside Analog AL-8176 In A Phase 2 Challenge Study In Adults Infected With Respiratory Syncytial Virus (RSV) At IDWeek

October 13, 2014
·
4 min read
Drug Development

Bioheart, Inc. Announces Positive 12 Month Preliminary Data From Phase I Angel Trial

October 13, 2014
·
3 min read
Business

SomaLogic, Inc. Announces Agreement To Place Somascan™ Proteomics Assay In National Institutes of Health (NIH) Center For Human Immunology, Autoimmunity And Inflammation

October 13, 2014
·
1 min read
Drug Development

Ipsen Announces Positive Results From Phase III Clinical Study Of Decapeptyl® (triptorelin pamoate) 11.25 mg Administered By Subcutaneous Route To Prostate Cancer Patients

October 13, 2014
·
1 min read
Orexo AB Submits Application To FDA For Expanded Label Of ZUBSOLV®

October 13, 2014
·
1 min read
Business

Nanobiotix Reaches The Second Milestone Payment Of BPIFrance Dedicated To NBTXR3 Development In Liver Cancers

October 13, 2014
·
3 min read
Drug Development

Concert Pharmaceuticals, Inc. Presents Positive Data From Multiple Dose Phase 1 Clinical Trial Of CTP-354, Lead Candidate For The Treatment Of Spasticity

October 13, 2014
·
1 min read
Drug Development

Alnylam Pharmaceuticals Reports Six-Month Clinical Data From Patisiran Phase 2 Open-Label Extension (OLE) Study In Patients With Familial Amyloidotic Polyneuropathy (FAP)

October 13, 2014
·
1 min read
Jinchi Biotech Ltd.'s Giant Salamander Glycopeptides Research Paper Published In “Chinese Medical Cosmetology”

October 13, 2014
·
1 min read
BioForest

ClearFlow Announces Positive Clinical Trial Results For The Reduction Of Hospital Complications After Heart Surgery

October 13, 2014
·
1 min read